These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9283786)

  • 21. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
    Zhuo X; Zhang P; Hoerger TJ
    Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic costs of diabetes: a population-based study in Tehran, Iran.
    Esteghamati A; Khalilzadeh O; Anvari M; Meysamie A; Abbasi M; Forouzanfar M; Alaeddini F
    Diabetologia; 2009 Aug; 52(8):1520-7. PubMed ID: 19475364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
    Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
    J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care.
    Currie CJ; Kraus D; Morgan CL; Gill L; Stott NC; Peters JR
    Diabet Med; 1997 Aug; 14(8):686-92. PubMed ID: 9272596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes managed care and clinical outcomes: the Harbor City, California Kaiser Permanente diabetes care system.
    Domurat ES
    Am J Manag Care; 1999 Oct; 5(10):1299-307. PubMed ID: 10622995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
    Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
    Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H
    Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managed care and diabetes, with special attention to the issue of who should provide care.
    Quickel KE
    Trans Am Clin Climatol Assoc; 1997; 108():184-95; discussion 196-9. PubMed ID: 9108677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.
    Yelin E; Herrndorf A; Trupin L; Sonneborn D
    Arthritis Rheum; 2001 May; 44(5):1160-9. PubMed ID: 11352250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.
    Pohar SL; Majumdar SR; Johnson JA
    Clin Ther; 2007; 29 Spec No():1316-24. PubMed ID: 18046931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of atrial fibrillation in United States managed care organizations.
    Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
    Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
    Cawley J; Meyerhoefer C; Biener A; Hammer M; Wintfeld N
    Pharmacoeconomics; 2015 Jul; 33(7):707-22. PubMed ID: 25381647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.
    Pohar SL; Majumdar SR; Johnson JA
    Clin Ther; 2007 Jun; 29(6 Pt 1):1316-24. PubMed ID: 18036393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991.
    Ray NF; Thamer M; Taylor T; Fehrenbach SN; Ratner R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3671-9. PubMed ID: 8855821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of improving primary care treatment of late-life depression.
    Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
    Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The costs of diabetes and its complications.
    Leese B
    Soc Sci Med; 1992 Nov; 35(10):1303-10. PubMed ID: 1439913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care expenditures for people with diabetes mellitus, 1992.
    Rubin RJ; Altman WM; Mendelson DN
    J Clin Endocrinol Metab; 1994 Apr; 78(4):809A-809F. PubMed ID: 8157701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Under-treatment of migrants with diabetes in a universalistic health care system: the ARNO Observatory.
    Marchesini G; Bernardi D; Miccoli R; Rossi E; Vaccaro O; De Rosa M; Bonora E; Bruno G
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):393-9. PubMed ID: 24462046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.